4D pharma plc Deferred Revenue Recognized
4D pharma plc reported Deferred Revenue Recognized of $718.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2022-03-31
| Period end | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|
| 2021-12-31 | $718.00K 20-F · filed 2022-03-31 | |
| 2021-06-30 | $321.00K 6-K/A · filed 2022-02-18 | |
| 2020-12-31 | $690.00K 20-F · filed 2022-03-31 | |
| 2020-06-30 | $239.00K 6-K/A · filed 2022-02-18 | |
| 2019-12-31 | $269.00K 20-F · filed 2022-03-31 |